Calcium signaling

ALZINC and NEXUS LIFE SCIENCES LAB INC. Unveil the Norige Youth Initiative, a Game-Changer in the Realm of Anti-Aging Technology

Retrieved on: 
Monday, October 23, 2023

ALZINC and NEXUS LIFE SCIENCES LAB INC. have introduced the Norige Youth Initiative, a pioneering global consortium that seeks to revolutionize anti-aging technology with the potential to extend the human lifespan and transform the societal and economic approach to aging and wellness.

Key Points: 
  • The Norige Youth Initiative is set to revolutionize our understanding of aging and promises to be a game-changer in the realm of anti-aging technology.
  • ALZINC and NEXUS LIFE SCIENCES LAB INC.
  • Unveil the Norige Youth Initiative, a Game-Changer in the Realm of Anti-Aging Technology
    To view an enhanced version of this graphic, please visit:
    This initiative represents a paradigm shift in the field of anti-aging research.
  • In unveiling the Norige Youth Initiative, ALZINC and NEXUS LIFE SCIENCES LAB INC. have embarked on a transformative journey in anti-aging technology.

GPCR Therapeutics Announces Publication in Nature Scientific Reports on Novel Anticancer Therapy

Retrieved on: 
Wednesday, March 15, 2023

The simultaneous expression of both receptors leads to the formation of CXCR4-HRH1 heteromer, and this complex demonstrates enhanced signalling and migration capabilities.

Key Points: 
  • The simultaneous expression of both receptors leads to the formation of CXCR4-HRH1 heteromer, and this complex demonstrates enhanced signalling and migration capabilities.
  • These findings suggest the interaction of CXCR4 and HRH1 may play an important role in cancer progression, thus serving as a potential therapeutic target for anticancer therapy.
  • This publication is significant as it represents the first case for our co-targeting drug development strategy to be peer-reviewed and validated in academia.
  • (1) Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration:

Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at the ADA's 83rd Scientific Sessions

Retrieved on: 
Tuesday, March 14, 2023

ARLINGTON, Va., March 14, 2023 /PRNewswire/ -- The American Diabetes Association® (ADA) is thrilled to announce the recipients of the 2023 National Scientific and Health Care Achievement Awards. The awards honor academics, health care providers, and educators who have contributed to substantial advances in the field of diabetes care and research. With the help of these leaders and their steadfast dedication, we move closer to achieving the mission of the ADA: To prevent and cure diabetes and to improve the lives of all people affected by diabetes.

Key Points: 
  • Dr. Tschöp's subsequent discovery of novel classes of dual and triple gut hormone drugs already transformed the fight against obesity and diabetes.
  • Carmella Evans-Molina, MD, PhD is the recipient of the 2023 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality.
  • He has published over 180 scientific papers in prestigious journals and is an international thought leader in the field of diabetes.
  • The ADA's 83rd Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in San Diego, CA on June 23–26.

Tactical Therapeutics, Inc., Developer of CTO Treatments for Glioblastoma, Selected to Present at MedInvest Oncology Investor Conference December 14-15 in New York

Retrieved on: 
Tuesday, December 13, 2022

Glioblastoma, the brain tumor that killed Senator Ted Kennedy, Beau Biden and Senator John McCain, is still mostly untreatable.

Key Points: 
  • Glioblastoma, the brain tumor that killed Senator Ted Kennedy, Beau Biden and Senator John McCain, is still mostly untreatable.
  • Recent reports suggest veterans of Vietnam, Iraq and Afghanistan wars who were exposed to burn pits later developed GBM.
  • GBM exhibits debilitating neurological symptoms and suicide rates for GBM patients are higher compared to those with other cancers.
  • Tactical Therapeutics, Inc., is a privately funded company that has developed a patented lead therapeutic, CTO, for glioblastoma and other solid cancers.

Prilenia Receives Fast Track Designation for Pridopidine for the Treatment of Huntington’s Disease

Retrieved on: 
Wednesday, November 17, 2021

Drugs with Fast Track designation may also qualify for accelerated approval and priority review of new drug applications.

Key Points: 
  • Drugs with Fast Track designation may also qualify for accelerated approval and priority review of new drug applications.
  • Pridopidine is currently being assessed in PROOF-HD (PRidopidine Outcome On Function in Huntington Disease), a global phase 3 clinical trial that very recently completed patient enrollment.
  • Receipt of Fast Track designation from the FDA underscores the urgency to address a significant unmet need for patients with Huntingtons Disease, said Dr. Michael R. Hayden, CEO and Founder of Prilenia.
  • Prilenia has been granted orphan drug designation for pridopidine for the treatment of HD in both the U.S. and Europe.

TARA Biosystems Partners with Scipher Medicine®

Retrieved on: 
Wednesday, November 3, 2021

TARA Biosystems , a biotechnology company harnessing human biology and data to transform cardiac drug discovery, today announced a collaboration with Scipher Medicine , a precision medicine company matching patients with the most effective therapy.

Key Points: 
  • TARA Biosystems , a biotechnology company harnessing human biology and data to transform cardiac drug discovery, today announced a collaboration with Scipher Medicine , a precision medicine company matching patients with the most effective therapy.
  • This collaboration demonstrates the transformative potential of combining biology-driven data with network biology to further drug discovery and development and unlock new medicines and therapeutics, said Misti Ushio, PhD, CEO of TARA Biosystems.
  • We believe that TARA and Scipher combined efforts have the potential to lead to drug development that enables a truly personalized treatment for patients.
  • Scipher Medicine, a precision immunology company, believes that patients deserve simple answers to treatment options based on scientifically backed data.

Prilenia Closes Oversubscribed $43 Million in Series B Financing Round

Retrieved on: 
Wednesday, November 3, 2021

Prilenia Therapeutics B.V. , a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that it has raised $43M in an oversubscribed Series B financing round.

Key Points: 
  • Prilenia Therapeutics B.V. , a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that it has raised $43M in an oversubscribed Series B financing round.
  • The funding round was upsized and led by new investor Sands Capital, alongside Forbion and Morningside.
  • The Series B financing brings the total capital invested in Prilenia Therapeutics since its founding in September 2018 to $133.5M.
  • "Prilenia has made tremendous progress since its founding through outstanding execution on all fronts, said Geert-Jan Mulder, MD, Prilenia Chairman and Managing Partner at Forbion.

UNCF and Bristol Myers Squibb Announce the 2021 Recipients of the E. E. Just Postgraduate Fellowship in Life Sciences

Retrieved on: 
Thursday, October 7, 2021

Washington, D.C., Oct. 07, 2021 (GLOBE NEWSWIRE) -- UNCF (United Negro College Fund) today announced the selection of two scientists for the E. E. Just Postgraduate Fellowship in the Life Sciences.

Key Points: 
  • Washington, D.C., Oct. 07, 2021 (GLOBE NEWSWIRE) -- UNCF (United Negro College Fund) today announced the selection of two scientists for the E. E. Just Postgraduate Fellowship in the Life Sciences.
  • Beasley and Brookens are outstanding bench scientists whose research will one day benefit patients who are battling serious diseases.
  • Created in 2017 by a partnership between UNCF and Bristol Myers Squibb (BMS), the E. E. Just Postgraduate Fellowship is a three-year award that provides recipients with an annual stipend that includes a base salary, benefits, research budget, and travel funds.
  • We are proud to continue our support of the E. E. Just Postgraduate Fellowship Program, and we congratulate Drs.

With LIFETAKT CELL ESSENCE, LR is Setting New Dietary Supplement Standards

Retrieved on: 
Monday, February 1, 2021

LR Health & Beauty has just launched a cutting-edge dietary supplement concept aimed at improving cell health: LR LIFETAKT CELL ESSENCE with the so-called Cell Boost Formula.

Key Points: 
  • LR Health & Beauty has just launched a cutting-edge dietary supplement concept aimed at improving cell health: LR LIFETAKT CELL ESSENCE with the so-called Cell Boost Formula.
  • On the one hand, this supports the energy supply and energy conversion1 within the cells as well as cell regeneration2,3.
  • LR LIFETAKT CELL ESSENCE meets peoples need for pioneering health support and for holistic solutions.
  • Calcium plays a role in cell division and cell specialisation.

New Survey Finds 84% of Parents Do Not Know How Much Calcium Their Children Need

Retrieved on: 
Tuesday, April 24, 2018

The survey revealed that more than half of respondents (52%) didn't know that bone health as an adult can be directly linked to calcium intake as a child.

Key Points: 
  • The survey revealed that more than half of respondents (52%) didn't know that bone health as an adult can be directly linked to calcium intake as a child.
  • In addition to bone-building calcium, just one eight-ounce serving of milk haseight grams of high-quality protein, which helps to build and repair muscle tissue.
  • In fact, one serving of milk provides calcium, riboflavin, phosphorus, vitamin B12, pantothenic acid, vitamin D, vitamin A and niacin.
  • Researchers have also found that eating foods rich in calcium may offset a possible protein-calcium loss relationship, improving overall bone health.